interferon
inhibit
innat
immun
nonstructur
protein
b
r
c
nonstructur
protein
porcin
reproduct
respiratori
syndrom
viru
partli
respons
inhibit
type
interferon
ifn
respons
infect
host
perform
alaninescan
mutagenesi
identifi
amino
acid
residu
proteolyt
product
substitut
alanin
exhibit
signific
relief
ifnsuppress
mutant
viru
residu
substitut
alanin
encod
mutant
recov
infecti
cdna
clone
shown
attenu
growth
vitro
induc
significantli
higher
amount
type
ifn
transcript
infect
macrophag
infect
pig
viru
exhibit
reduc
growth
earli
time
infect
quickli
regain
wild
type
growth
properti
result
substitut
within
mutat
sequenc
result
indic
strong
select
pressur
toward
maintain
ifninhibitori
properti
viru
success
propag
pig
identif
amino
acid
residu
import
antiifn
activ
porcin
reproduct
respiratori
syndrom
viru
nonstructur
protein
introduct
porcin
reproduct
respiratori
syndrom
prr
signific
anim
diseas
affect
swine
herd
porkproduc
countri
two
major
clinic
manifest
diseas
late
term
reproduct
failur
pregnant
sow
respiratori
distress
young
piglet
well
grow
pig
annual
econom
loss
result
prr
usa
swine
industri
alon
estim
million
miller
recent
largescal
outbreak
high
fever
diseas
china
unusu
high
mortal
rate
add
signific
swine
pathogen
tian
et
al
etiolog
agent
diseas
prr
viru
prrsv
envelop
positivesens
singlestrand
rna
viru
genom
kb
prrsv
belong
famili
arterivirida
along
coronavirida
ronivirida
famili
form
order
nidoviral
cavanagh
member
arterivirida
famili
includ
equin
arter
viru
eav
lactat
dehydrogenaseelev
viru
ldv
simian
hemorrhag
fever
viru
shfv
viral
genom
encod
open
read
frame
orf
translat
gener
polyprotein
process
viral
proteas
form
differ
nonstructur
protein
nsp
fang
snijder
snijder
meulenberg
sever
nsp
identifi
integr
member
viral
replic
transcript
machineri
other
might
involv
process
interact
host
cell
factor
beura
et
al
fang
snijder
furthermor
nsp
also
like
regul
viral
pathogenesi
involv
modul
host
innat
immun
respons
type
interferon
ifn
constitut
major
player
host
innat
immun
respons
system
viral
replic
intermedi
like
doubl
strand
rna
dsrna
sens
cytoplasm
rigi
like
helicas
well
endosom
tolllik
receptor
sensor
trigger
complex
signal
cascad
bowi
unterholzn
kawai
akira
signal
event
culmin
activ
sever
transcript
factor
includ
interferon
regulatori
factor
nuclear
factor
kappa
b
nfkb
activ
transcript
transcript
factor
coordin
drive
express
type
ifn
gene
secret
ifn
bind
cognat
receptor
cell
surfac
initi
janu
kinas
jak
signal
transduc
activ
transcript
stat
signal
pathway
lead
synthesi
ifnstimul
gene
isg
isg
establish
antivir
state
cours
evolut
virus
develop
numer
strategi
counteract
ifn
product
signal
pathway
ensur
propag
host
versteeg
garciasastr
infect
prrsv
result
poor
type
ifn
product
vitro
infect
macrophag
infect
pig
albina
et
al
lee
et
al
low
level
ifn
induct
process
activ
suppress
viru
sinc
infect
strong
ifninduc
transmiss
gastroenter
coronaviru
tgev
prrsv
infect
could
elicit
detect
ifn
product
albina
et
al
nsp
prrsv
inhibit
ifndepend
transcript
earlier
report
five
differ
nsp
inhibit
ifnb
gene
transcript
protein
suppress
nfkb
mediat
ifn
gene
induct
chen
et
al
song
et
al
also
interfer
ifn
signal
specif
jakstat
pathway
patel
et
al
prrsv
interfer
nfkb
signal
deubiquitin
ubiquitin
ikba
molecul
import
nfkb
activ
expos
prrsv
anim
develop
viremia
last
month
viru
still
detect
certain
secondari
lymphoid
tissu
month
infect
allend
et
al
will
et
al
level
variou
proinflammatori
cytokin
import
compon
host
innat
immun
respons
besid
ifn
low
compar
induc
sever
respiratori
swine
pathogen
van
reeth
et
al
van
reeth
nauwynck
subsequ
develop
effector
compon
adapt
immun
respons
eg
neutral
antibodi
antigenspecif
tcell
delay
lopez
osorio
robust
adapt
immun
respons
depend
proper
prime
innat
immun
respons
henc
initi
suboptim
innat
respons
hypothes
respons
delay
defect
develop
adapt
immun
respons
kimman
et
al
murtaugh
et
al
thu
prrsv
effici
suppress
type
ifn
induct
predict
stimul
strong
adapt
immun
respons
culmin
rapid
clearanc
prssv
nan
et
al
object
studi
map
domainsresidu
prrsv
respons
inhibit
mediat
gene
induct
use
alaninescan
mutagenesi
identifi
residu
protein
also
abl
recov
viru
mutat
protein
character
mutant
viru
demonstr
viru
attenu
growth
induc
higher
level
type
ifn
vitro
howev
mutat
unstabl
vivo
revert
viru
quickli
regain
abil
suppress
ifn
product
infect
pig
identif
residu
pcpa
domain
prrsv
import
inhibit
ifn
product
previous
other
demonstr
prrsv
inhibitor
ifnb
induct
chen
et
al
current
experi
intend
map
residuesdomain
involv
suppress
ifn
product
alanin
substitut
aa
aa
made
ntermin
zinc
finger
domain
aa
pcpa
domain
aa
sun
et
al
alanin
scan
mutant
design
aa
residu
number
first
aa
follow
number
residu
mutat
alanin
eg
mutant
aa
residu
number
substitut
alanin
possibl
substitut
might
affect
correct
process
junction
proteas
import
viru
viabil
ensur
correct
process
junction
singl
amino
acid
substitut
made
background
fulllength
express
plasmid
protein
render
inact
promot
inhibit
first
check
success
cleavag
junction
subject
report
assay
report
vector
contain
tandem
repeat
ifnstimul
respons
element
isr
promot
element
activ
report
assay
mutant
show
mutant
involv
amino
acid
residu
reliev
ifnsuppress
properti
fig
howev
residu
part
mutant
none
mutant
ntermin
zinc
finger
domain
abl
reliev
ifnsuppress
four
singl
amino
acid
substitut
mutant
aa
aa
region
show
almost
complet
relief
inhibitori
effect
fig
sinc
sever
viral
proteas
regul
ifn
product
degrad
certain
signal
intermedi
ifn
induct
pathway
li
et
al
li
et
al
possibl
ifn
suppress
activ
mediat
proteas
activ
exact
proteas
activ
site
protein
determin
basi
pairwis
sequenc
align
strain
use
studi
lelystad
strain
kroes
et
al
examin
whether
proteolyt
activ
essenti
ifnantagon
gener
mutant
contain
alanin
substitut
proteas
activ
site
residu
mutant
alter
ifnsuppress
abil
fig
thu
mutat
studi
identifi
four
specif
amino
acid
prrsv
respons
ifnantagon
sever
amino
acid
stretch
involv
ifnsuppress
function
subsequ
experi
intend
map
residuesdomain
involv
suppress
ifn
product
initi
six
mutant
made
aa
block
delet
abil
reduc
ifnsuppress
analyz
report
assay
surpris
mutant
complet
reliev
ifninhibitori
properti
wt
data
shown
suggest
aa
block
delet
might
result
gross
deform
protein
tertiari
structur
like
result
nonfunct
protein
thu
effect
promot
therefor
decid
perform
alaninescan
mutagenesi
short
amino
acid
stretch
aa
wt
replac
alanin
crystal
structur
prrsv
solv
protein
found
possess
three
distinct
domain
ntermin
nucleas
domain
aa
aa
linker
domain
aa
aa
ctermin
cystein
proteas
domain
aa
aa
xue
et
al
three
domain
target
mutagenesi
residu
mutat
well
conserv
among
type
ii
prrsv
strain
result
differ
mutant
test
protein
express
abil
suppress
promot
activ
wide
variat
protein
express
level
differ
mutant
rel
wt
transient
transfect
assay
mutant
exhibit
higher
level
protein
accumul
other
show
lower
level
wt
fig
bottom
report
assay
result
show
variabl
degre
allevi
ifnsuppress
effect
highest
exhibit
relief
fig
top
cystein
proteas
activ
essenti
proteolyt
process
junction
lead
releas
polyprotein
examin
whether
proteolyt
activ
essenti
ifnantagon
gener
mutant
individu
proteas
activ
site
mutat
alanin
test
ifninhibitori
properti
assay
mutant
show
similar
even
stronger
suppress
promot
measur
respons
dsrna
stimul
fig
conclud
proteas
activ
site
critic
regul
ifn
induct
taken
togeth
identifi
sever
mutant
mutat
locat
three
domain
reduc
abil
suppress
induct
depend
promot
respons
dsrna
treatment
alaninescan
mutagenesi
experi
describ
identifi
sever
mutant
protein
exhibit
reduc
abil
suppress
ifn
induct
respons
dsrna
next
object
recov
virus
encod
mutant
protein
present
studi
focus
mutant
rather
ifn
promot
suppress
exhibit
mutant
less
potent
specif
concentr
ntermin
nucleas
domain
prrsv
certain
viral
nucleas
shown
prevent
induct
type
ifn
matzen
et
al
nucleas
depend
manner
five
nucleas
domain
mutant
gener
earlier
first
three
chosen
prepar
viru
sinc
show
higher
allevi
ifninhibit
also
compar
level
protein
express
wild
type
wt
use
standard
revers
genet
approach
recov
mutant
virus
describ
earlier
kwon
et
al
truong
et
al
h
postelectropor
full
length
infecti
rna
cell
immunostain
viral
nucleocapsid
protein
indic
sg
mrna
transcript
well
viral
protein
indic
viral
replic
three
differ
mutant
attempt
rescu
abl
recov
one
viru
contain
two
virus
reduc
abil
antagon
mediat
gene
induct
luciferas
assay
perform
alanin
scan
mutant
singl
amino
acid
substitut
mutant
b
proteas
activ
mutant
c
cell
cotransfect
indic
mutantwt
express
plasmid
mg
empti
vector
vector
plasmid
mg
prltk
mg
h
posttransfect
cell
treat
mgml
dsrna
h
assay
luciferas
activ
panel
bar
graph
show
protein
express
respect
mutant
detect
use
antiflag
antibodi
bar
repres
averag
n
rel
promot
activ
compar
vector
control
convert
mutant
whose
promot
activ
significantli
differ
wt
indic
asterisk
n
po
betaactin
serv
load
control
show
sign
viral
replic
sg
rna
synthesi
indic
absenc
nucleocapsid
protein
stain
immunofluoresc
data
shown
alter
protein
local
affect
protein
function
check
local
upon
transient
transfect
hela
cell
fig
wt
mutant
display
similar
nuclear
cytoplasm
local
describ
next
compar
vitro
growth
characterist
mutant
viru
parent
wt
prrsv
strain
monocytederiv
macrophag
although
multistep
growth
kinet
virus
appear
similar
mutant
viru
grew
titer
averag
one
log
lower
compar
wt
viru
fig
reduct
titer
evid
time
point
examin
similar
growth
attenu
also
observ
permiss
monkey
kidney
cell
line
data
shown
taken
togeth
studi
show
mutant
viru
growth
attenu
vitro
mutat
alter
natur
local
panel
bar
graph
show
protein
express
respect
mutant
detect
use
antiflag
antibodi
bar
repres
averag
rel
promot
activ
compar
vector
control
convert
mutant
whose
promot
activ
significantli
differ
wt
indic
asterisk
n
po
betaactin
serv
load
control
increas
type
ifn
induct
respons
prrsv
infect
monocytederiv
macrophag
next
object
investig
whether
mutant
prrsv
induc
higher
level
type
ifn
compar
wt
viru
end
monocytederiv
macrophag
mockinfect
infect
moi
wt
prrsv
mutant
viru
total
rna
isol
cell
porcin
ifna
ifnb
mrna
copi
number
determin
realtim
pcr
type
ifn
induc
significantli
higher
level
viru
infect
macrophag
compar
wt
viru
three
differ
time
point
test
fig
b
follow
ifn
synthesi
upregul
product
hundr
isg
one
therefor
check
protein
level
cell
infect
wt
mutant
viru
moder
increas
level
mutant
virusinfect
cell
compar
wt
virusinfect
cell
fig
observ
indic
mutant
viru
exhibit
reduc
abil
suppress
ifn
induct
compar
wt
prrsv
pursu
vivo
character
mutant
viru
compar
parent
viru
wt
two
group
specif
pathogen
free
young
pig
n
infect
either
wt
mutant
viru
level
viremia
measur
determin
viral
rna
copi
number
sera
differ
time
postinfect
anim
infect
viru
show
reduc
viremia
compar
wt
viru
infect
anim
earli
time
postinfect
dpi
fig
howev
later
time
eg
dpi
dpi
differ
mutant
wt
viru
insignific
rapid
recoveri
growth
mutant
viru
led
us
hypothes
mutant
viru
might
accumul
certain
mutat
enabl
attain
growth
properti
similar
wt
prssv
examin
sequenc
region
viru
serum
infect
anim
dpi
dpi
dpi
observ
alanin
threonin
substitut
amino
acid
posit
dpi
infect
anim
fig
anim
also
accumul
anoth
mutat
dpi
alanin
posit
revert
valin
parent
amino
acid
posit
dpi
mutat
still
present
mutat
observ
amino
acid
sequenc
led
us
investig
whether
result
revert
tv
mut
could
reliev
ifn
suppress
base
assay
tv
mut
show
similar
ifnsuppress
abil
wt
offer
relief
suppress
unlik
mutant
fig
result
suggest
rapid
growth
recoveri
mutant
viru
mediat
mutat
aa
aa
posit
led
regain
ifnsuppress
abil
research
perform
far
relat
antiifn
activ
includ
protein
overexpress
overexpress
might
lead
atyp
express
unusu
local
protein
lead
artifactu
function
respons
concern
approach
question
whether
act
ifnantagonist
context
viru
infect
end
tradit
method
would
call
develop
viru
without
ifn
antagonist
properti
follow
check
relief
ifn
suppress
howev
sinc
requir
viral
sg
mrna
synthesi
process
polyprotein
two
crucial
step
viral
life
cycl
imposs
complet
remov
viral
genom
kroes
et
al
therefor
perform
alaninescan
mutagenesi
map
residu
involv
ifnsuppress
approach
predict
better
chanc
recov
mutant
virus
replic
identifi
sever
discontinu
stretch
encompass
three
domain
respons
inhibit
mediat
gene
induct
possibl
differ
stretch
might
target
distinct
step
ifn
signal
pathway
circumst
could
distinguish
end
point
luciferas
assay
interestingli
none
alanin
mutant
could
provid
complet
relief
suppress
express
individu
fig
suggest
multipl
region
need
inhibit
ifn
product
sinc
alanin
mutant
cover
whole
sequenc
presenc
region
includ
assay
antiifn
activ
rule
time
unlik
could
precis
locat
singl
amino
acid
level
ifnantagon
three
mutant
consecut
locat
exhibit
complet
relief
inhibit
gene
induct
three
amino
acid
import
homodim
interact
present
surfac
protein
accord
newli
describ
crystal
structur
sun
et
al
therefor
possibl
homodimer
may
requir
ifn
inhibitori
activ
cystein
proteas
proteas
activ
essenti
correct
process
viral
polyprotein
mutat
proteas
activ
site
residu
affect
antiifn
function
observ
line
previou
find
proteas
capabl
cisproteolyt
activ
cleav
viral
polyprotein
releas
polyprotein
ceas
activ
proteas
sun
et
al
xue
et
al
contrari
view
shi
et
al
report
mutat
proteas
activ
site
result
loss
antiifn
properti
discord
might
explain
use
full
length
plasmid
assay
mutat
proteas
activ
residu
construct
prevent
process
matur
might
import
ifn
inhibit
altern
explan
would
amino
acid
use
substitut
serin
cystein
tyrosin
histidin
might
affect
normal
protein
structur
compar
alanin
substitut
interestingli
recent
report
laboratori
also
implic
amino
acid
found
studi
involv
interf
tnfa
mrna
synthesi
subramaniam
et
al
effort
recov
virus
mutat
nucleas
domain
limit
success
could
recov
one
mutant
viru
possibl
ifnantagonist
defici
virus
becam
suscept
antivir
action
ifn
produc
transfect
vitro
transcript
viru
recoveri
process
transcript
possess
triphosph
group
strong
induc
rigi
signal
schlee
et
al
avoid
endogen
ifn
induct
use
cell
impair
rigi
signal
habjan
et
al
howev
repeat
transfect
experi
cell
could
recov
abovement
viru
evid
genom
replic
immunofluoresc
stain
sg
mrna
synthesi
nucleocapsid
immunofluoresc
stain
case
remain
construct
besid
role
sg
rna
transcript
prrsv
involv
viral
polyprotein
process
check
proper
protein
cleavag
transfer
mutat
nonrecover
virus
fulllength
mutant
show
reduc
process
polyprotein
corrobor
proper
cleavag
essenti
viral
replic
data
shown
sever
studi
indic
ifn
antagonist
knockout
virus
exhibit
sever
growth
defect
vitro
promptli
clear
vivo
host
ifn
respons
richt
garciasastr
report
pursu
character
one
mutant
viru
viru
exhibit
slow
growth
kinet
monocytederiv
macrophag
abl
attain
maxim
titer
tcid
ml
growth
abil
might
due
residu
ifn
suppress
activ
viru
encod
four
fulli
function
ifn
antagonist
nsp
previous
describ
mutant
viru
show
delay
growth
kinet
vivo
eventu
reach
titer
equival
wt
prrsv
dpi
abnorm
vivo
kinet
growth
due
revers
mutat
revert
obtain
revert
viru
show
equal
effect
ifnsuppress
wt
gainoffunct
mutat
like
contribut
viru
abil
attain
wt
growth
possibl
minor
speci
viru
mutat
may
appear
routin
passag
cell
cultur
prepar
stock
inocul
howev
sequenc
control
standard
sanger
sequenc
inocul
viru
give
indic
nevertheless
indic
strong
select
pressur
residu
growth
insid
host
interestingli
first
residu
replac
alanin
posit
polar
residu
threonin
dpi
natur
amino
acid
posit
lysin
implic
nucleas
activ
xue
et
al
suggest
respons
stabil
bound
nucleic
acid
posit
charg
pocket
form
nucleas
domain
presenc
threonin
posit
recov
tv
mut
viru
indic
presenc
polar
residu
might
essenti
function
nucleas
activ
turn
might
import
effici
vivo
viral
replic
altern
nucleas
activ
requir
viru
multipl
mutat
alanin
alon
suffici
allevi
ifnsuppress
abil
luciferas
assay
suggest
nucleas
activ
probabl
import
ifn
modul
data
shown
note
howev
possibl
role
nucleas
activ
transcript
factor
mediat
ifn
induct
exclud
prrsv
innat
immun
antagonist
action
attract
consider
attent
recent
year
result
research
enhanc
understand
biolog
role
protein
known
mechan
ifnsuppress
includ
inhibit
ikb
phosphoryl
prevent
nuclear
transloc
nfkb
mode
action
includ
inhibit
phosphoryl
nuclear
transloc
well
inhibit
nuclear
transloc
chen
et
al
patel
et
al
addit
kim
et
al
shown
express
target
crebbind
protein
cbp
proteasom
degrad
howev
precis
mechan
regard
achiev
multipl
function
need
identifi
import
exact
map
residu
involv
ifn
regul
summari
result
confirm
ifninhibitori
natur
prrsv
context
viru
infect
alaninescan
mutagenesi
identifi
amino
acid
import
antiifn
properti
protein
mutant
viru
induc
significantli
higher
level
ifn
mrna
vitro
quickli
revert
vivo
acquir
ifnsuppress
abil
futur
studi
includ
thorough
scan
viral
protein
identifi
residu
involv
ifn
antagon
mutat
studi
like
especi
challeng
case
prrsv
would
target
multipl
nsp
essenti
viral
replic
cycl
inclus
vitro
replicationtranscript
assay
along
ifnrel
assay
help
segreg
ifninhibitori
domain
replic
domain
protein
acceler
find
success
candid
mutat
ampl
exampl
virus
ration
design
modif
remov
antiifn
properti
without
alter
replic
potenti
inform
studi
incorpor
develop
effect
control
strategi
prrsv
obtain
dr
laegreid
usmarc
usdaar
kim
et
al
invivogen
cell
maintain
dmem
contain
fetal
bovin
serum
mgml
gentamicin
sigma
porcin
monocytederiv
macrophag
prepar
peripher
blood
mononuclear
cell
describ
previous
love
et
al
briefli
mononuclear
cell
isol
blood
donor
pig
ficol
densiti
centrifug
use
lymphocyt
separ
medium
mediatech
cell
allow
attach
glass
petridish
one
day
follow
wash
pb
enrich
monocyt
attach
monocyt
cultur
rpmi
medium
supplement
bvdvfree
fetal
bovin
serum
presenc
macrophag
coloni
stimul
factor
ngml
sigma
day
order
induc
differenti
macrophag
monocytederiv
macrophag
harvest
cell
dissoci
buffer
gibco
seed
rpmi
fb
viru
infect
infecti
clone
deriv
genotyp
ii
prrsv
strain
truong
et
al
propag
cell
prepar
viru
stock
studi
variou
mutant
virus
also
propag
cell
upon
recoveri
virus
passag
use
vitro
experi
well
anim
inocul
sendai
viru
cantel
strain
obtain
charl
river
laboratori
use
haemagglutin
unitml
concentr
infect
cell
plasmid
describ
earlier
subramaniam
et
al
block
delet
mutant
prepar
overlap
extens
pcr
method
differ
alanin
substitut
mutant
describ
subramaniam
et
al
prepar
sitedirect
mutagenesi
megaprim
pcr
method
sarkar
sommer
mutant
construct
ntermin
flag
tag
antibodi
use
studi
sourc
followssdow
antiprrsv
n
monoclon
antibodi
nelson
et
al
purchas
nation
veterinari
servic
laboratori
nvsl
ame
ia
mous
antibactin
obtain
santa
cruz
biotech
antiflag
rabbit
antiflag
product
sigma
aldrich
secondari
antibodi
conjug
hrp
purchas
kirkegaard
perri
ltd
kpl
includ
goat
antimous
goat
antirabbit
antibodi
prrsv
antibodi
develop
immun
rabbit
protein
could
detect
antibodi
gener
gift
dr
saumendra
sarkar
u
pittsburg
dr
eric
j
snijder
lumc
netherland
respect
report
assay
perform
describ
earlier
minor
modif
briefli
cell
transfect
mg
report
plasmid
ng
prltk
promega
along
indic
protein
express
vector
use
transit
miru
bio
per
manufactur
protocol
twenti
four
hour
posttransfect
media
replac
fresh
media
h
posttransfect
cell
either
treat
mgml
poli
poli
c
ge
health
care
pb
h
luciferas
assay
perform
use
dual
luciferas
assay
kit
promega
firefli
luciferas
activ
express
percentag
respect
control
normal
renilla
luciferas
activ
empti
vector
transfect
dsrna
stimul
cell
normal
ifn
realtim
pcr
total
rna
isol
viru
infectedmockinfect
monocytederiv
macrophag
use
trizol
invitrogen
reagent
treat
dnase
cdna
synthesi
mg
rna
revers
transcrib
use
oligodt
primer
mmlv
revers
transcript
kit
invitrogen
per
manufactur
recommend
next
cdna
use
realtim
pcr
quantit
indic
mrna
copi
number
smartcycl
machin
cepheid
use
faststart
univers
probe
mastermix
roch
cycl
condit
use
initi
denatur
min
amplif
cycl
swine
ifna
b
bactin
intern
control
real
time
pcr
perform
use
taqman
probe
base
method
describ
earlier
ifna
ifnb
mrna
level
virusinfect
cell
express
copi
number
rel
mockinfect
cell
per
method
describ
earlier
stordeur
et
al
ifn
mrna
level
normal
across
experi
use
porcin
bactin
intern
control
measur
viral
rna
copi
number
singl
step
taqmanbas
revers
transcriptionr
time
pcr
use
hot
startit
probe
one
step
qrtpcr
master
mix
affymetrix
design
viral
rna
isol
use
qiagen
viral
rna
mini
kit
qiagen
ml
serum
infect
pig
follow
manufactur
instruct
isol
rna
ml
use
pcr
reaction
rna
copi
number
calcul
use
standard
curv
gener
vitro
transcript
probe
primer
use
probe
tcacctattcaattagggcgaccg
forward
primer
atgtgtggtgaatggcactg
revers
primer
gcatggttctcgccaattaaa
pcr
target
type
ii
prrsv
cycl
condit
pcr
wererevers
transcript
min
initi
denatur
min
amplif
cycl
overexpress
experi
indic
plasmid
transfect
cell
use
invitrogen
transit
miru
bio
per
manufactur
protocol
h
transfect
cell
wash
twice
pb
collect
lysat
prepar
lysi
perform
lysi
buffer
mm
tri
mm
nacl
mm
edta
mm
egta
triton
mm
sodium
pyrophosph
mm
bglycerophosph
mm
sodium
orthovanad
complet
proteas
inhibitor
roch
clarif
rpm
min
lysat
resolv
sdspage
follow
transfer
onto
polyvinylidenedifluorid
pvdf
membran
millipor
membran
block
block
buffer
tri
buffer
salin
contain
nonfat
dri
milk
tween
h
follow
incub
indic
primari
antibodi
membran
wash
incub
horseradish
peroxidas
hrp
conjug
secondari
antibodi
final
protein
visual
ecl
detect
system
pierc
gener
full
length
prrsv
vitro
transcript
describ
earlier
kwon
et
al
truong
et
al
briefli
mutant
fulllength
plasmid
linear
acli
restrict
enzym
digest
dna
phenol
chloroform
purifi
mg
dna
use
templat
ml
vitro
transcript
reaction
use
mmessagemmachin
ultra
kit
ambion
per
manufactur
recommend
result
cap
polyadenyl
full
length
rna
purifi
phenol
chloroform
use
electropor
reaction
cell
electropor
describ
previous
kwon
et
al
truong
et
al
electropor
cell
seed
dmem
media
contain
fb
cell
regularli
check
develop
cytopath
effect
viru
growth
also
confirm
indirect
immunofluoresc
use
antin
antibodi
upon
confirm
viru
growth
supernat
plate
collect
clarifi
supernat
label
passag
amplifi
prepar
stock
subsequ
studi
multipl
step
growth
curv
monocytederiv
macrophag
infect
multipl
infect
moi
indic
virus
cultur
supernat
collect
indic
time
post
viral
infect
store
titrat
titrat
supernat
perform
cell
express
tissu
cultur
infecti
dose
per
ml
tcid
ml
per
spearman
karber
method
anim
studi
perform
accord
protocol
approv
institut
anim
care
use
committe
univers
nebraskalincoln
four
sixweek
old
pig
n
purchas
specif
pathogenfre
herd
certifi
record
prrsv
absenc
pig
randomli
divid
two
group
inocul
tcid
ml
total
ml
inoculum
wt
prrsv
viru
inoculum
divid
equal
inocul
intramuscular
well
intranas
rout
viremia
measur
realtim
pcr
sera
collect
day
postinfect
dpi
